What Myelofibrosis Patients Should Know about Bone Marrow Transplants

Dalton joined HealthTree in 2024 as the MPNs and MDS Program Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.

Dr. Palmer has a clinical interest in myeloproliferative neoplasms, as well as bone marrow transplantation. Her interest is in identifying novel, targeted therapies for patients with myeloproliferative neoplasms, such as essential thrombocythemia, polycythemia vera, and myelofibrosis. She strives to offer innovative therapies to patients in all stages of their disease through clinical trials. She also participates in quality of life research, to understand what factors not only contribute to longevity, but also quality of life. When seeing patients, her focus is on providing appropriate education regarding their disease, to help in a shared decision making process. This ensures that patients receive the care most appropriate for them. In addition to her clinical activities, she serves as the Vice Chair, and Section Chief for Hematology. She also is the Program Director for the Blood and Marrow Transplant Program. She also teaches at the Mayo Clinic Medical School in Arizona, as well as University of Arizona in Phoenix.